Viz.ai announced two abstracts on Viz HCM, the AI-ECG algorithm in the Viz Cardio Suite, accepted for the HCMS meeting held with AHA Scientific Sessions 2026. A University of Colorado study of ECGs from more than 29,000 patients found nearly 40 percent of patients flagged for suspected HCM had no matching diagnosis code, and a Beth Israel Deaconess study found flagged patients had a 2.68 fold higher hazard of adverse clinical events.
Our readAdds real world evidence from two academic centers that the HCM algorithm finds patients missed by diagnosis code searches and standard ECG reads, which bears on the case finding yield a health system can expect. Both studies were funded by Bristol Myers Squibb through Viz.ai, so buyers should weigh them as sponsored abstracts, not peer reviewed papers.